| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Celltech R&D, Slough, Berkshire, United Kingdom; and
Celltech R&D, Great Abington, Cambridge, United Kingdom
Dendritic cells (DC) are essential to the initiation of an immune response due to their unique ability to take-up and process Ag, translocate to lymph nodes, and present processed Ag to naive T cells. Many chemokines, chemokine receptors and other G protein-coupled receptors (GPCRs) are implicated in these various aspects of DC biology. Through microarray analysis, we compared expression levels of chemokines, their cognate receptors, and selected GPCRs in human monocytes and in vitro monocyte-derived immature and mature DC. Hierarchical clustering of gene expression clearly distinguishes the three cell types, most notably highlighting exceptional levels of expression of the GPCR GPR105 within the immature monocyte-derived DC (MDDC) gene cluster. Little or no expression was observed within the monocyte and mature MDDC cluster. Putative functionality of the GPR105 receptor was demonstrated by an observed calcium flux in immature MDDC treated with the potent GPR105 agonist, uridine 5'-diphosphoglucose (UDP-glucose), while no response to the nucleotide sugar was seen in monocytes and mature MDDC. This UDP-glucose-induced calcium response was, at least in part, pertussis toxin-sensitive. Moreover, immature MDDC from some donors treated with UDP-glucose exhibit an increase in expression of the costimulatory molecule CD86, which correlates with the intensity of the UDP-glucose-induced calcium flux. Together, these data demonstrate differential expression of GPR105 on immature and mature MDDC and suggest a role for the receptor and its agonist ligand in DC activation.
This article has been cited by other articles:
|
|
 |
|
  R. L. Carter, I. P. Fricks, M. O. Barrett, L. E. Burianek, Y. Zhou, H. Ko, A. Das, K. A. Jacobson, E. R. Lazarowski, and T. K. Harden Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor Mol. Pharmacol., December 1, 2009; 76(6): 1341 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. P. Fricks, R. L. Carter, E. R. Lazarowski, and T. K. Harden Gi-Dependent Cell Signaling Responses of the Human P2Y14 Receptor in Model Cell Systems J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 162 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Arase, H. Uchida, T. Kajitani, M. Ono, K. Tamaki, H. Oda, S. Nishikawa, M. Kagami, T. Nagashima, H. Masuda, et al. The UDP-Glucose Receptor P2RY14 Triggers Innate Mucosal Immunity in the Female Reproductive Tract by Inducing IL-8 J. Immunol., June 1, 2009; 182(11): 7074 - 7084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Sesma, C. R. Esther Jr., S. M. Kreda, L. Jones, W. O'Neal, S. Nishihara, R. A. Nicholas, and E. R. Lazarowski Endoplasmic Reticulum/Golgi Nucleotide Sugar Transporters Contribute to the Cellular Release of UDP-sugar Signaling Molecules J. Biol. Chem., May 1, 2009; 284(18): 12572 - 12583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bassil, S. Bourdu, K. A. Townson, A. Wheeldon, E. M. Jarvie, N. Zebda, A. Abuin, E. Grau, G. P. Livi, L. Punter, et al. UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G923 - G930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jiang, L. Borrelli, B. J. Bacskai, Y. Kanaoka, and J. A. Boyce P2Y6 Receptors Require an Intact Cysteinyl Leukotriene Synthetic and Signaling System to Induce Survival and Activation of Mast Cells J. Immunol., January 15, 2009; 182(2): 1129 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. P. Fricks, S. Maddileti, R. L. Carter, E. R. Lazarowski, R. A. Nicholas, K. A. Jacobson, and T. K. Harden UDP Is a Competitive Antagonist at the Human P2Y14 Receptor J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 588 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ricciardi, A. R. Elia, P. Cappello, M. Puppo, C. Vanni, P. Fardin, A. Eva, D. Munroe, X. Wu, M. Giovarelli, et al. Transcriptome of Hypoxic Immature Dendritic Cells: Modulation of Chemokine/Receptor Expression Mol. Cancer Res., February 1, 2008; 6(2): 175 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Khine, L. Del Sorbo, R. Vaschetto, S. Voglis, E. Tullis, A. S. Slutsky, G. P. Downey, and H. Zhang Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway Blood, April 1, 2006; 107(7): 2936 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ferrari, A. la Sala, E. Panther, J. Norgauer, F. Di Virgilio, and M. Idzko Activation of human eosinophils via P2 receptors: novel findings and future perspectives J. Leukoc. Biol., January 1, 2006; 79(1): 7 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Muller, H. Bayer, D. Myrtek, D. Ferrari, S. Sorichter, M. W. Ziegenhagen, G. Zissel, J. C. Virchow Jr., W. Luttmann, J. Norgauer, et al. The P2Y14 Receptor of Airway Epithelial Cells: Coupling to Intracellular Ca2+ and IL-8 Secretion Am. J. Respir. Cell Mol. Biol., December 1, 2005; 33(6): 601 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Shellenberger, M. Wang, M. Gujrati, A. Jayakumar, R. M. Strieter, M. D. Burdick, C. G. Ioannides, C. L. Efferson, A. K. El-Naggar, D. Roberts, et al. BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells Cancer Res., November 15, 2004; 64(22): 8262 - 8270. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
